Dallas, TX — (SBWIRE) — 02/28/2011 — GBI Research, the leading business intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific Region-Threat of Pandemic Influenza and Increasing Vaccination Coverage to Drive Growth” which essentially provides insights on seasonal influenza vaccine sales forecasts for the Asia-Pacific Region until 2016. The report also delves deep into vaccination patterns for seasonal influenza in the Asia-Pacific Region. Further, the geographical distribution of seasonal influenza vaccines across Australia, New Zealand, Taiwan, Philippines, Hong Kong and Singapore are also provided in the report. The report offers a clear view of the regulatory landscape in the Asia-Pacific countries. The report also includes insights into the seasonal influenza vaccine R&D pipeline and offers profiles of promising vaccines. The report explores the competitive landscape including profiles for top companies. Finally, the key trend analysis on mergers and acquisitions, and licensing agreements involving seasonal influenza vaccines is also presented.
[Note from SaneVax: The title says it all in this one–the threat of pandemic influenza and increasing vaccination coverage to drive growth. The SaneVax Team finds it appalling that reports are created to show manufacturers how to use threats to sell their products……especially vaccines where there is no legal means to raise product liability issues should something go wrong.]